Viatris Inc


SKU: VTRS-1 Category:


Viatris Inc.: Strategic Expansion Into Key Therapeutic Verticals


Viatris Inc. reported its Q4 and Full Year 2023 Earnings with strong operational results, showing revenue growth for the third consecutive quarter. As Viatris begins 2024, it continues to generate strong free cash flows that provide the flexibility to balance capital return to shareholders and strategic investments for future growth. In terms of investment thesis, Viatris demonstrated a robust performance in 2023, finishing the year with a total revenue of approximately $15.4 billion. The firm also closed certain divestitures and is expected to complete all remaining divestitures by mid-2024, subject to regulatory approval. These moves have streamlined the company’s operations, showing management’s active efforts in achieving its financial targets. Moreover, Viatris maintained its dividend for 2024 and initiated share repurchases, providing shareholders attractive returns.

Our Report Structure:

⦁ Company Overview
⦁ Investment Thesis
⦁ Key Drivers
⦁ Historical Quarterly Statement Analysis – Income Statement & Cash Flows
⦁ Historical Quarterly Balance Sheet Analysis
⦁ Historical Annual Financial Statement Analysis
⦁ Analysis Of Key Financial Ratios
⦁ Financial Forecasts For 3 Years
⦁ Forecasting The Capital Structure & Net Debt
⦁ Discounted Cash Flow Valuation
⦁ Trading Multiples
⦁ Key Risks
⦁ Disclosures

Want unlimited access to our reports? Purchase our $99 annual subscription!